AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Sectors:
Analyst Ranking
Bottom 13%
#3998 out of 4560 analysts
Average Return
-9.43%
Win Rate
23%3 out of 13
Risk vs Reward
Poor
Good
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jasper Therapeutics IncJSPR | 1 | Buy | $65.00 | +193.98% | Initiates Coverage On | 21 days ago |
Sarepta Therapeutics IncSRPT | 6 | Hold | $138.00 | +17.83% | Maintains | 2 months ago |
Argenx SeARGX | 2 | Buy | $436.00 | +16.24% | Maintains | 4 months ago |
Mirum Pharmaceuticals IncMIRM | 1 | Buy | $62.00 | +153.89% | Reinstates | 6 months ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | +1,703.28% | Initiates Coverage On | 7 months ago |
C4 Therapeutics IncCCCC | 1 | Buy | $10.00 | +44.93% | Maintains | a year ago |
Abbvie IncABBV | 2 | Buy | $165.00 | N/A | Maintains | a year ago |
Inhibrx IncINBX | 1 | Buy | $60.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.